Health Press Release – Monthly Newsletter March 2011
Verona Pharma Applies for Approval to Test RPL554 in UK Clinical Trials
LONDON, January 31, 2011 - Verona Pharma plc (AIM:VRP.L) the biotechnology company dedicated to
discovering new drugs for the treatment of chronic respiratory diseases, has
applied to the Medicines and Healthcare Products Regulatory Agency (MHRA),
the Governmental agency in the UK with responsibility for standards of
safety, quality and performance of new drug treatments, to conduct clinical
trials in .... Source article on Gaea Times at : Verona Pharma Applies for Approval to Test RPL554 in UK Clinical Trials.
Health Press Release – Monthly Newsletter February 2011
AMP's SIVAC Initiative Supports the Creation of a Mongolian National Immunization Technical Advisory Group (NITAG)
PARIS, January 4, 2011 - The inaugural meeting of the Mongolian National Immunization Technical
Advisory Group (NITAG) was held at the Ministry of Health in Ulaanbaatar on
December 6, 2010.
The NITAG is the first of its kind in Mongolia and was established based
on recommendations from the World Health Organization (WHO). The committee's
role .... Source : Gaea News Network.
Health Press Release – Monthly Newsletter January 2011
IDEV Technologies Announces First U.S. Procedure With SUPERA VERITAS(TM) Transhepatic Biliary System
Commercial Launch of Stent Delivery System Planned for Early 2011
WEBSTER, Texas, November 30, 2010 - IDEV Technologies, Incorporated (IDEV), an innovative leader in the
development and commercialization of minimally invasive medical technologies,
today announced the first procedure in the United States utilizing the SUPERA
VERITAS(TM) Transhepatic Biliary System, which was recently cleared to market
by the U.S. Food .... Source article on Gaea Times at : IDEV Technologies Announces First U.S. Procedure With SUPERA VERITAS(TM) Transhepatic Biliary System.
Health Press Release – Monthly Newsletter December 2010
General Manifolds LLC Announces Issuance of US Patent in Computational Neuroscience
CARLSBAD, California, November 1, 2010 - General Manifolds LLC, a technology company focused on fundamental
cognitive algorithms, announced today that the United States Patent and
Trademark Office has issued US Patent 7,805,386 covering a computational
system and method for simulating functions within the cerebral cortex of the
human brain. This ground-breaking technology is relevant to a broad range ... Read : General Manifolds LLC Announces Issuance of US Patent in Computational Neuroscience.
Health Press Release – Monthly Newsletter November 2010
Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R&D Alliance
Sanofi-Aventis Names Covance its R&D Partner as part of US$2.2 Billion Agreement -
PRINCETON, New Jersey, September 30, 2010 - Covance Inc. (NYSE: CVD) today announced the signing of definitive
agreements with sanofi-aventis (EURONEXT: SAN and NYSE: SNY) for Covance to
become sanofi-aventis' R&D partner. Over the next ten years, Covance expects
to provide drug development services to [...]